Literature DB >> 12030346

Impact of the cross-sectional geometry of the post-deployment coronary stent on in-stent neointimal hyperplasia: an intravascular ultrasound study.

Takashige Murata1, Takafumi Hiro, Takashi Fujii, Kyounori Yasumoto, Akihiro Murashige, Masateru Kohno, Jyutaro Yamada, Toshiro Miura, Masunori Matsuzaki.   

Abstract

To establish the relationship between the cross-sectional geometry of the post-deployment stent and the degree of in-stent neointimal hyperplasia (INH), intravascular ultrasound (IVUS) was used to examine cross-sections of the coronary arteries from 23 patients with coronary stents 6 months after implantation. Stent cross-sectional area (Sa) and stent perimeter (Sp) from 200 stent cross-sections, and the stent radius (Sr) and thickness of INH (Id) of 2,880 radial axes, were measured, and the mean degree of roundness (Rd) of stent cross-section was calculated for each stent as Rd=4piSa/Sp2. The degree of deformity (Df) of the stent cross-section was also calculated by comparing it with a hypothetical circle (the area of this hypothetical circle was equal to the Sa): Df=Sr/R, where R is the radius of the hypothetical circle. The area of INH was significantly larger in the Rd<0.87 group (n=84) than in the Rd> or =0.87 group (n=116) (3.83+/-1.26 vs 3.16+/-1.32 mm2, p<0.0005). There were significant differences in the thickness of INH among the 3 groups classified by the value of Df (Df<0.95: n=425, 0.21+/-0.12mm; 0.95< or =Df<1.05: n=2008, 0.29+/-0.15mm; Df> or =1.05: n=447, 0.34+/-0.15mm, overall p<0.0001). These data suggest that in-stent neointimal proliferation is more likely to occur in stented coronary arteries with a more oval than rounded cross-section, and particularly within the more pronounced and curved portion of the oval.

Entities:  

Mesh:

Year:  2002        PMID: 12030346     DOI: 10.1253/circj.66.489

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  6 in total

1.  Evaluation of in-stent neointimal tissue components using integrated backscatter intravascular ultrasound: comparison of drug-eluting stents and bare-metal stents.

Authors:  Yoshitaka Muraoka; Shinjo Sonoda; Kuninobu Kashiyama; Fumihiko Kamezaki; Yuki Tsuda; Masaru Araki; Masahiro Okazaki; Yutaka Otsuji
Journal:  Int J Cardiovasc Imaging       Date:  2011-12-18       Impact factor: 2.357

2.  Modelling intravascular delivery from drug-eluting stents with biodurable coating: investigation of anisotropic vascular drug diffusivity and arterial drug distribution.

Authors:  Xiaoxiang Zhu; Daniel W Pack; Richard D Braatz
Journal:  Comput Methods Biomech Biomed Engin       Date:  2012-04-18       Impact factor: 1.763

3.  Evaluation of local flow conditions in jailed side branch lesions using computational fluid dynamics.

Authors:  Sang-Hoon Na; Bon-Kwon Koo; Jeong Chul Kim; Han-Mo Yang; Kyung-Woo Park; Hyun-Jae Kang; Hyo-Soo Kim; Byung-Hee Oh; Young-Bae Park
Journal:  Korean Circ J       Date:  2011-02-28       Impact factor: 3.243

4.  Image-based quantification of 3D morphology for bifurcations in the left coronary artery: Application to stent design.

Authors:  Laura Ellwein; David S Marks; Raymond Q Migrino; W Dennis Foley; Sara Sherman; John F LaDisa
Journal:  Catheter Cardiovasc Interv       Date:  2015-11-19       Impact factor: 2.692

5.  Axial stent strut angle influences wall shear stress after stent implantation: analysis using 3D computational fluid dynamics models of stent foreshortening.

Authors:  John F LaDisa; Lars E Olson; Douglas A Hettrick; David C Warltier; Judy R Kersten; Paul S Pagel
Journal:  Biomed Eng Online       Date:  2005-10-26       Impact factor: 2.819

6.  Alterations in regional vascular geometry produced by theoretical stent implantation influence distributions of wall shear stress: analysis of a curved coronary artery using 3D computational fluid dynamics modeling.

Authors:  John F LaDisa; Lars E Olson; Hettrick A Douglas; David C Warltier; Judy R Kersten; Paul S Pagel
Journal:  Biomed Eng Online       Date:  2006-06-16       Impact factor: 2.819

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.